RepliCel Life Sciences organizacji Cena/wartość księgowa
Jaka jest wartość Cena/wartość księgowa organizacji RepliCel Life Sciences?
Wartość Cena/wartość księgowa organizacji RepliCel Life Sciences, Inc. to -0.77
Jaka jest definicja Cena/wartość księgowa?
Wskaźnik ceny do sprzedaży(Price to book ratio) reprezentuje stosunek wartości akcji spółki do wartości księgowej na akcję.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Cena/wartość księgowa firm w Health Care sektor na TSXV w porównaniu do RepliCel Life Sciences
Czym się zajmuję organizacja RepliCel Life Sciences?
RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01, which has completed Phase I clinical trials for the treatment of chronic tendinosis; RCS-01 that is in Phase 2 clinical trials to treat aging and sun damaged skin; and RCH-01, which is in Phase 2 clinical trials for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. It also has a collaboration research project agreement with the University of British Columbia to build a hair follicle cell data map. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada.
Firmy z cena/wartość księgowa podobne do RepliCel Life Sciences
- Wartość Cena/wartość księgowa organizacji Gayatri Sugars to -0.77
- Wartość Cena/wartość księgowa organizacji CVR Medical to -0.77
- Wartość Cena/wartość księgowa organizacji QDM International to -0.77
- Wartość Cena/wartość księgowa organizacji Collaborate to -0.77
- Wartość Cena/wartość księgowa organizacji TrustBIX to -0.77
- Wartość Cena/wartość księgowa organizacji Starlite Components to -0.77
- Wartość Cena/wartość księgowa organizacji RepliCel Life Sciences to -0.77
- Wartość Cena/wartość księgowa organizacji Bitcoin Well Inc to -0.76
- Wartość Cena/wartość księgowa organizacji Wheeler Real Estate Investment Trust Inc to -0.76
- Wartość Cena/wartość księgowa organizacji Pioneer Distilleries to -0.76
- Wartość Cena/wartość księgowa organizacji Maple Leaf Green World to -0.76
- Wartość Cena/wartość księgowa organizacji Management Consulting PLC to -0.75
- Wartość Cena/wartość księgowa organizacji Alok Industries to -0.75